Inventor · disambiguated record
Grigorios Nikitidis
Also filed as: NIKITIDIS GRIGORIOS
9 granted patents·4 pending applications·20 citations·filing 2002–2021
81Inventor score
Top patents by PatentIndex Score
13 records- 0184US11274091B2Cyclopentane compoundsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2020·Granted Mar 15, 2022·2 cites·9 claims
- 0277US7868188B25-heteroaryl thiazoles and their use as PI3K inhibitorsASTRAZENECA AB·Filed 2005·Granted Jan 11, 2011·8 cites·16 claims
- 0368US7030246B2Tetrahydroquinoline derivatives as stat6-modulators, preparation and use thereofASTRAZENECA AB·Filed 2002·Granted Apr 18, 2006·9 cites·14 claims
- 0459US12378218B2Cyclopentane compoundsDIZAL JIANGSU PHARMACEUTICAL CO LTD·Filed 2021·Granted Aug 5, 2025·0 cites·15 claims
- 0559US10954211B2Chemical compoundsASTRAZENECA AB·Filed 2019·Granted Mar 23, 2021·0 cites·11 claims
- 0657US7410966B2Use of and some novel imidazopyridinesASTRAZENECA AB·Filed 2003·Granted Aug 12, 2008·1 cites·4 claims
- 0755US10336725B2Chemical compoundsASTRAZENECA AB·Filed 2017·Granted Jul 2, 2019·0 cites·3 claims
- 0849US9873678B2Chemical compoundsASTRAZENECA AB·Filed 2015·Granted Jan 23, 2018·0 cites·4 claims
- 0945US9657001B2Compounds and usesASTRAZENECA AB·Filed 2016·Granted May 23, 2017·0 cites·4 claims
- 1043US2009233907A1Pyridopyrimidine Derivatives and Their Use as PDE4 InhibitorsASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 1142US2008227797A1Pyridopyrimidine Derivatives as Pde4 Inhibitors for the Treatment of Inflammatory and Immune DiseasesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1241US2006035938A12-Pyridone derivatives as inhibitors of neutrophile elastaseBLADH HAKAN·Filed 2003·Application pending·0 cites
- 1340US2017216283A1Compounds and usesASTRAZENECA AB·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Grigorios Nikitidis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →